- Home
- MDV vs INMB Comparison
MDV vs INMB Comparison
Compare MDV & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDV
- INMB
- Stock Information
- Founded
- MDV 2015
- INMB 2015
- Country
- MDV United States
- INMB United States
- Employees
- MDV N/A
- INMB N/A
- Industry
- MDV Transportation Services
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- MDV Consumer Discretionary
- INMB Health Care
- Exchange
- MDV Nasdaq
- INMB Nasdaq
- Market Cap
- MDV 149.1M
- INMB 176.5M
- IPO Year
- MDV 2022
- INMB 2019
- Fundamental
- Price
- MDV $14.59
- INMB $6.38
- Analyst Decision
- MDV
- INMB Strong Buy
- Analyst Count
- MDV 0
- INMB 3
- Target Price
- MDV N/A
- INMB $24.33
- AVG Volume (30 Days)
- MDV 41.2K
- INMB 660.2K
- Earning Date
- MDV 08-05-2025
- INMB 07-31-2025
- Dividend Yield
- MDV 7.95%
- INMB N/A
- EPS Growth
- MDV N/A
- INMB N/A
- EPS
- MDV N/A
- INMB N/A
- Revenue
- MDV $46,738,000.00
- INMB $50,000.00
- Revenue This Year
- MDV $2.21
- INMB $82.14
- Revenue Next Year
- MDV $4.45
- INMB $28,750.98
- P/E Ratio
- MDV N/A
- INMB N/A
- Revenue Growth
- MDV N/A
- INMB N/A
- 52 Week Low
- MDV $13.62
- INMB $4.32
- 52 Week High
- MDV $18.11
- INMB $10.50
- Technical
- Relative Strength Index (RSI)
- MDV 52.07
- INMB 37.45
- Support Level
- MDV $14.01
- INMB $6.68
- Resistance Level
- MDV $14.61
- INMB $8.05
- Average True Range (ATR)
- MDV 0.31
- INMB 0.62
- MACD
- MDV 0.07
- INMB -0.10
- Stochastic Oscillator
- MDV 62.37
- INMB 10.31
About MDV Modiv Industrial Inc. Class C
Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.